Utility of 18F-Fluciclovine PET/CT for Detecting Prostate Cancer Recurrence in Patients With Low (< 1 ng/mL) or Very Low (< 0.3 ng/mL) Prostate-Specific Antigen Levels

被引:8
|
作者
Wang, Yingbing [1 ]
Chow, David Z. [1 ]
Ebert, Emily [1 ]
Tajmir, Shahein [1 ]
Scott, James A. [1 ]
Palmer, Edwin L. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St,Wht 4-427, Boston, MA 02114 USA
关键词
biochemical recurrence; fluciclovine PET; prostate cancer; C-11-CHOLINE PET/CT; RELAPSE; TOMOGRAPHY; F-18-FACBC;
D O I
10.2214/AJR.19.22180
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. We reviewed a retrospective series of 126 F-18-fluciclovine PET/CT studies of patients with biochemically recurrent prostate cancer at low (< 1 ng/mL) and very low (< 0.3 ng/mL) prostate-specific antigen (PSA) levels. CONCLUSION. The rate of PET/CT positivity was 33% (15/46) in patients with low PSA levels and 0% (0/17) in patients with very low PSA levels. Our results suggest that F-18-fluciclovine PET/CT can be helpful for localizing recurrence in patients with PSA levels between 0.3 and 1 ng/mL and that F-18-fluciclovine PET/CT is not recommended in patients with PSA levels less than 0.3 ng/mL.
引用
收藏
页码:997 / 1001
页数:5
相关论文
共 50 条
  • [1] Utility of 18F-Fluciclovine PET/CT for Detecting Prostate Cancer Recurrence in Patients With Low (< 1 ng/mL) or Very Low (&lt; 0.3 ng/mL) Prostate-Specific Antigen Levels (vol 215, pg 997, 2020)
    Wang, Yingbing
    Chow, David Z.
    Ebert, Emily
    Tajmir, Shahein
    Scott, James A.
    Palmer, Edwin L.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (05) : 1299 - 1299
  • [2] Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels
    Marcus, Charles
    Abiodun-Ojo, Olayinka A.
    Jani, Ashesh B.
    Schuster, David M.
    [J]. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 406 - 414
  • [3] 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels &lt;2.00 ng/mL
    Garza, Daniel
    Kandathil, Asha
    Xi, Yin
    Subramaniam, Rathan M.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (08) : 907 - 913
  • [4] Performance of 18F-Fluciclovine PET/CT for detection of recurrent prostate cancer, with a focus on low PSA levels (&lt; 1 ng/mL): A single institution experience.
    Sue, Veronia
    Brown, Adam
    Mittra, Erik
    Mallak, Nadine
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [5] Positive Findings on 18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer and PSA levels ≤ 0.5 and ≤ 0.3 ng/ml
    Lovec, P.
    Savir-Baruch, B.
    Gupta, G.
    Wagner, R.
    Gabriel, M. S.
    Harkenrider, M. M.
    Solanki, A. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S161 - S161
  • [6] Solitary Penile Metastasis of Prostate Cancer on 18F-Fluciclovine PET/CT Imaging in a Patient With PSA of 1 ng/mL
    Salavati, Ali
    Schik, Allyssa N.
    Koksel, Yasemin
    Gencturk, Mehmet
    Froelich, Jerry W.
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : 389 - 391
  • [7] Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL
    El Bulbul, Jad
    Grybowski, Damian
    Lovrec, Petra
    Solanki, Abhishek A.
    Gabriel, Medhat S.
    Wagner, Robert H.
    Savir-Baruch, Bital
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (01) : 42 - 49
  • [8] Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL
    Jad El Bulbul
    Damian Grybowski
    Petra Lovrec
    Abhishek A. Solanki
    Medhat S. Gabriel
    Robert H. Wagner
    Bital Savir-Baruch
    [J]. Molecular Imaging and Biology, 2022, 24 : 42 - 49
  • [9] Using 18F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA Levels
    Siegel, Barry A.
    Schuster, David M.
    Savir-Baruch, Bital
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 216 (03) : W10 - W10
  • [10] Role of 18F-Choline PET/CT in restaging patients with prostate cancer with trigger PSA &lt; 1 ng/ml
    Marzola, M. C.
    Chondrogiannis, S.
    Ferretti, A.
    Maffione, A. M.
    Rampin, L.
    Massaro, A.
    Grassetto, G.
    Rubello, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S286 - S286